A client with hypertension appears at the clinic for follow-up. The client's BP is 138/88 mm Hg. The client asks why it is important to treat hypertension. What would be the nurse's best response?

A. "This medication should be taken before going to bed.": HMG-CoA reductase inhibitors like simvastatin are most effective when administered in the evening. Most endogenous cholesterol synthesis occurs during the night while the patient is fasting. Timing the dose at bedtime ensures peak drug levels coincide with the body's highest rate of production.

B. "You should take these medications first thing in the morning on an empty stomach.": Administering statins in the morning reduces their efficacy because the peak plasma concentration occurs when cholesterol synthesis is at its lowest. Unlike some medications, simvastatin does not require an empty stomach for absorption. Morning dosing is generally avoided for statins with shorter half-lives.

C. "You should take this medication in the morning with your breakfast to prevent upset stomach.": While taking medication with food can reduce gastric irritation, the morning timing is pharmacologically suboptimal for simvastatin. Standard nursing practice emphasizes evening administration to maximize the inhibition of the cholesterol-producing enzyme. This instruction would decrease the overall therapeutic benefit.

D. "You should take this medication with your mid-day meal with food.": Mid-day dosing does not align with the circadian rhythm of hepatic cholesterol synthesis. For maximal lipid-lowering effects, the medication must be present during the nocturnal hours. Afternoon administration is not the standard of care for short-acting statin therapy.

A. A marker of cardiac muscle damage: Troponin is a protein found specifically in cardiac myocytes that is released into the bloodstream when the heart muscle is injured. Elevated levels are the most specific and sensitive laboratory indicator for diagnosing an acute myocardial infarction. It allows healthcare providers to differentiate between unstable angina and true myocardial necrosis.

B. A level of an electrolyte that when abnormal may cause chest pain: Electrolytes such as potassium or magnesium can cause arrhythmias when abnormal, but they are not troponins. Troponin is a structural protein, not a charged ion involved in cellular electrical potential. Monitoring electrolytes is important in cardiac care, but it is distinct from the necrotic marker testing.

C. A marker of the amount of stretch the ventricle has done: The marker for ventricular stretch and fluid volume overload is Brain Natriuretic Peptide (BNP), not troponin. BNP is used to diagnose and monitor the severity of heart failure. Troponin specifically indicates cell death and injury rather than the degree of volume expansion or pressure within the heart.

D. A level of liver enzyme that can be elevated with right sided heart failure: Liver enzymes like ALT and AST may rise during systemic venous congestion, but they are not cardiac-specific. Troponin has no diagnostic value for liver function or hepatic congestion. It is used exclusively to evaluate the integrity of the myocardial tissue during suspected ischemic events.